Lihat Juga

• INVESTIGATIVE CRITIQUE OF THE PAPER ENTITLED " HYDROXYCHLOROQUINE AND AZITHROMYCIN AS A TREATMENT OF COVID-19: RESULTS OF AN OPEN-LABEL NON-RANDOMIZED CLINICAL TRIAL", AUTHORED BY GAUTRET, P., LAGIER, J.-C., PAROLA, P., HOANG, V.T., MEDDEB, L., MAILHE, M., DOUDIER, B., COURJON, J., GIORDANENGO, V., VIEIRA, V.E., TISSOT, H., HONERE, S., LA SCOLA, B., ROLAIN, J.-M., BROUQUI, P. AND RAOULT, D., AND PUBLISHED IN INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS [(INT. J. ANTIMICROB. AGENTS (2020), DOI:10.1016/J.IJANTIMICAG.2020.105949]
  oleh: Tung, H.Y. Lim
  Terbitan: (2020)
• Chloroquine and hydroxychloroquine for COVID-19 treatment
  oleh: Nugrahaningsih, Dwi Aris Agung, et al.
  Terbitan: (2020)
• The Off-Label Use of Hydroxychloroquine in Prophylaxis and Treatment of COVID-19
  oleh: Ashish Paul
  Terbitan: (2020)
• Hydroxychloroquine is Effective and Safe for the Treatment of COVID-19, and May be Universally Effective When Used Early Before Hospitalization: A Systematic Review
  oleh: Chadwick Prodromos, et al.
  Terbitan: (2020)
• Hydroxychloroquine is Effective and Safe for the Treatment of COVID-19, and May be Universally Effective When Used Early Before Hospitalization: A Systematic Review
  oleh: Chadwick Prodromos, et al.
  Terbitan: (2020)